Cargando…

Targeted therapy in advanced non-small cell lung cancer: current advances and future trends

Lung cancer remains the leading cause of cancer-related mortality in both men and women in the US and worldwide. Non-small cell lung cancer is the most common variety accounting for 84% of the cases. For a subset of patients with actionable mutations, targeted therapy continues to provide durable re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majeed, Umair, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264982/ https://www.ncbi.nlm.nih.gov/pubmed/34238332 http://dx.doi.org/10.1186/s13045-021-01121-2

Ejemplares similares

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
por: Wiest, Nathaniel, et al.
Publicado: (2021)

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023)

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
por: Seegobin, Karan, et al.
Publicado: (2021)

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report
por: Majeed, Umair, et al.
Publicado: (2023)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literature
por: Seegobin, Karan, et al.
Publicado: (2020)

Trends in participant race and sex reporting in lung cancer phase III clinical trials
por: Aslam, Faaiq N., et al.
Publicado: (2023)

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies
por: Soyano, Aixa E., et al.
Publicado: (2018)

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
por: Lou, Yanyan, et al.
Publicado: (2018)

Immunotherapies targeting stimulatory pathways and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer
por: Zhou, Kexun, et al.
Publicado: (2021)

Crizotinib‐associated renal cyst development may be associated with prolonged progression‐free survival in patients with ALK‐positive non‐small‐cell lung cancer: Case report and review of the literature
por: Wiest, Nathaniel E., et al.
Publicado: (2021)

Locally advanced non-small cell lung cancer: current issues and recent trends
por: Alaswad, Mohammed
Publicado: (2023)

Genomic landscape of lung adenocarcinomas in different races
por: Shi, Huashan, et al.
Publicado: (2022)

Targeted therapies for advanced non-small cell lung cancer
por: Ai, Xiaojuan, et al.
Publicado: (2018)

Bioactive Phenolics and Polyphenols: Current Advances and Future Trends
por: Jacobo-Velázquez, Daniel A., et al.
Publicado: (2020)

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
por: de Mello, Ramon Andrade, et al.
Publicado: (2020)

Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma
por: Olszanski, Anthony J.
Publicado: (2014)

MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends
por: Xu, Qiaoyu, et al.
Publicado: (2021)

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
por: Liang, Jiaqi, et al.
Publicado: (2022)

Brief report: risk stratification following curative therapy for stage I NSCLC
por: Butts, Emily, et al.
Publicado: (2023)

Clinical Immunology of Cholera - Current Trends and Directions for Future Advancement
por: Chiappelli, Francesco, et al.
Publicado: (2017)

Recent advances of novel targeted therapy in non-small cell lung cancer
por: Katzel, Jed A, et al.
Publicado: (2009)

Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
por: Stinchcombe, Thomas E
Publicado: (2007)

Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
por: Wakelee, Heather, et al.
Publicado: (2018)

Perioperative systemic therapies for non-small-cell lung cancer: Recent advances and future perspectives
por: Lampridis, Savvas, et al.
Publicado: (2023)

PD‐1/PD‐L1 Blockade Therapy in Advanced Non‐Small‐Cell Lung Cancer: Current Status and Future Directions
por: Xia, Liliang, et al.
Publicado: (2019)

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
por: Zhong, Lei, et al.
Publicado: (2021)

mRNA vaccine in cancer therapy: Current advance and future outlook
por: Li, Youhuai, et al.
Publicado: (2023)

Advanced Issues and Future Trends
por: Ioannis Baltopoulos
Publicado: (2005)

Recent Advancements in Nanobiosensors: Current Trends, Challenges, Applications, and Future Scope
por: Kulkarni, Madhusudan B., et al.
Publicado: (2022)

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
por: Le, Alexander D, et al.
Publicado: (2017)

Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in Context
por: Gullapalli, Sneha, et al.
Publicado: (2020)

Recent advances in non-small cell lung cancer targeted therapy; an update review
por: Araghi, Mahmood, et al.
Publicado: (2023)

A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
por: Sh Ahmed, Omar, et al.
Publicado: (2022)

Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
por: Diebels, Ian, et al.
Publicado: (2022)

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
por: Suraya, Ratoe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bjfppm0smbhr4jo2u44511k2ge